Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis

Bone Marrow Transplantation volume 35, pages 213–214 (2005)Cite this article

Angioedema, characterized by intermittent attacks of peripheral edema due to extravasation of fluids into interstitial tissues, results from the release of inflammatory mediators that lead to enhanced permeability of capillaries and venules as well as dilatation of blood vessels.

Clinical characteristics include rapid onset of edema, involvement of tongue, cheeks, upper airways and bowel and asymmetric distribution.1,2

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Markovic SN, Inwards DJ, Frigas EA, Phyliky RP . Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000; 132: 144–150.

    Article  CAS  Google Scholar 

  2. Ugochukwu CN, Frigas E, Tremaine WJ . Hereditary angioedema. Arch Intern Med 2001; 161: 2417–2429.

    Article  Google Scholar 

  3. Oltvai ZN, Wong EC, Atkinson JP, Tung KS . C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 1991; 65: 381–388.

    CAS  PubMed  Google Scholar 

  4. Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C . Clinical and biological distinction between type I and type II acquired angioedema. Am J Med 2003; 115: 420–421.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, University of Montreal, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada

    T L Kiss

  2. Department of Medical Oncology and Hematology, University of Toronto, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada

    H A Messner & J Lipton

  3. Department of Hematology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada

    A Galal

Authors
  1. T L Kiss
    View author publications

    Search author on:PubMed Google Scholar

  2. H A Messner
    View author publications

    Search author on:PubMed Google Scholar

  3. A Galal
    View author publications

    Search author on:PubMed Google Scholar

  4. J Lipton
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiss, T., Messner, H., Galal, A. et al. Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis. Bone Marrow Transplant 35, 213–214 (2005). https://doi.org/10.1038/sj.bmt.1704748

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704748

This article is cited by

Search

Advanced search

Quick links